ArticleRevista cientifica odontologica (Universidad Cientifica del Sur)
[Photobiomodulation with active oxygen and lactoferrin in the treatment of medication-related osteonecrosis of the jaw. A case report].
Article in Revista cientifica odontologica (Universidad Cientifica del Sur). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diode-laser-assisted biopsy and photobiomodulation therapy in the management of Sjögren's disease: a case report.Journal of medical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication-related osteonecrosis jaw (MRONJ) affects about 5% of patients treated with bisphosphonates and other similar drugs. This case report describes the management of a case of MRONJ using photobiomodulation therapy (FBM) combined with active oxygen and lactoferrin (Blue®M). This is a 62-year-old patient with hypertension, rheumatoid arthritis and osteoporosis treated with Bonames®. After extraction, she presented exposed bone in the alveolar ridge of quadrant III. Under informed consent, minimally invasive surgery was performed with electrical instruments (Piezotome®). Histopathological analysis revealed necrotic bone tissue with chronic inflammatory infiltrate. The treatment included Blue®M teeth&bone once a day for 30 days, topical application of Blue®M gel every morning for 15 days and FBM with 808nm diode laser (Therapy-DMC®). The laser sessions were daily until day 3, and then twice a week for four weeks. The patient also performed mouthwashes with Blue®M every night for 30 days. Initially, the patient reported pain of 3/10 on the visual analog scale, which decreased to 0/10 at the end of treatment. Clinically, soft tissue healing was observed at 30 days and 60 days and the CT scan showed hyperdense cancellous bone with well-formed cortical and no alterations. Finally, this case suggests that the combination of FBM with topical active oxygen therapy and lactoferrin, along with minimally invasive surgical intervention, holds promise for the management of MRONJ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.